Unexpected and abnormally low HDL cholesterol levels on combination hypolipidemic therapy.
Ranjit Unnikrishnan, Rabindra Nath Das, Revale Jaydip, C Sudhakaran, Viswanathan Mohan
Abstract
Ranjit Unnikrishnan, Rabindra Nath Das, Revale Jaydip, C Sudhakaran, Viswanathan Mohan
Abstract
In general, Indians have low HDL cholesterol levels. Fenofibrate, a drug widely used in the treatment of hypertriglyceridemia, usually also increases HDL cholesterol. There have been a few reports in the literature of a paradoxical decrease in serum HDL-cholesterol in patients treated with fenofibrate, either alone or in combination with a statin. We report three cases of paradoxical decrease in serum HDL-cholesterol in type 2 diabetic patients treated with a statin-fenofibrate combination.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In general, Indians have low HDL cholesterol levels. Fenofibrate, a drug widely used in the treatment of hypertriglyceridemia, usually also increases HDL cholesterol. There have been a few reports in the literature of a paradoxical decrease in serum HDL-cholesterol in patients treated with fenofibrate, either alone or in combination with a statin. We report three cases of paradoxical decrease in serum HDL-cholesterol in type 2 diabetic patients treated with a statin-fenofibrate combination.
Key concepts: Fenofibrate, Medicine, Hypertriglyceridemia, Internal medicine, Cholesterol, Statin, Endocrinology, Combination therapy